UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~April~~May 2025

Commission File Number: 001-39461

NANO-X IMAGING LTD

Ofer Tech Park

94 Shlomo Shmeltzer Road

Petach Tikva

Israel 4970602

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

On ~~April~~May 1722, 2025, ~~Nano~~NANO-X ~~Imaging~~IMAGING ~~Ltd.~~LTD (the “Company”) ~~announced~~issued ~~that~~a itpress ~~has~~release ~~received~~announcing ~~510(k)~~the ~~clearance~~Company’s ~~from~~results ~~the~~of ~~U.S.~~operation ~~Food~~for ~~and~~the ~~Drug~~first ~~Administration~~quarter ~~(FDA)~~ended ~~for~~March ~~the~~31, ~~Nanox.ARC X~~2025, ~~its~~and ~~new~~providing ~~multi-source~~a ~~digital~~business ~~tomosynthesis system~~update. ~~The~~A ~~FDA~~copy ~~510(k) clearance covers the production~~ of ~~tomographic~~that ~~images~~press ~~for~~release ~~general~~is ~~use,~~attached ~~including~~hereto ~~the~~as ~~human musculoskeletal~~Exhibit ~~system and pulmonary~~99.1, ~~intra-abdominal~~ and ~~paranasal~~incorporated ~~sinus~~herein ~~indications,~~by ~~adjunctive to conventional radiography, on adult patients~~reference.

~~The~~In ~~contents~~addition ofto ~~Exhibit~~reporting ~~99.1~~the toCompany’s ~~this Form~~financial ~~6-K,~~results ~~excluding statements~~ in ~~quotes~~accordance ~~included~~with ~~therein,~~generally ~~are~~accepted ~~incorporated~~accounting byprinciples ~~reference~~in ~~into~~ the ~~registration~~United ~~statements~~States ~~on Form F-3~~ (~~File No. 333-271688~~“GAAP”), ~~and~~the onpress ~~Form~~release also ~~S-8~~includes ~~(File~~certain ~~No.~~financial ~~333-248322)~~measures offor the Company,’s ~~filed~~performance ~~with~~that ~~the~~are ~~Securities~~not ~~and~~prepared ~~Exchange~~in ~~Commission,~~accordance towith beGAAP adue ~~part~~to ~~thereof from~~ the ~~date~~exclusion onof ~~which~~certain ~~this~~expenses ~~report~~that isare ~~submitted,~~required to ~~the~~be ~~extent~~included ~~not~~under ~~superseded by documents or reports subsequently filed or furnished~~GAAP.

For information on the Company’s GAAP and non-GAAP financial results for the period, please refer to the press release.

The GAAP financial statements tables contained in the press release attached as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K are incorporated by reference into the Company’s Registration Statements on Form F-3, File No. 333-271688, and Form S-8, File No. 333-248322.

EXHIBIT INDEX

Exhibit No.		Exhibit
99.1		Press release, dated ~~April~~May 1722, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

NANO-X IMAGING LTD. By: /s/ Ran Daniel Name: Ran Daniel Title: Chief Financial Officer

Date: ~~April~~May 1722, 2025

Filing Compare · Nano-X Imaging Ltd.